A Small‐Molecule Ratiometric Photoacoustic Probe for High‐Spatiotemporal‐Resolution Imaging of Copper(II) Dynamics in the Mouse Brain

Zhiyong Jiang,Changli Zhang,Xiaoqing Wang,Zongxin Ling,Yuncong Chen,Zijian Guo,Zhipeng Liu
DOI: https://doi.org/10.1002/anie.202318340
2024-02-03
Angewandte Chemie International Edition
Abstract:Copper dysmetabolism is associated with various neurodegenerative disorders, making high-spatiotemporal-resolution imaging of Cu2+ in the brain essential for understanding the underlying pathophysiological processes. Nevertheless, the current probes encounter obstacles in crossing the blood-brain barrier (BBB) and providing high-spatial-resolution in deep tissues. Herein, we present a photoacoustic probe capable of imaging Cu2+ dynamics in the mouse brain with high-spatiotemporal-resolution. The probe demonstrates selective ratiometric and reversible responses to Cu2+, while also efficiently crossing the BBB. Using the probe as the imaging agent, we successfully visualized Cu2+ in the brain of Parkinson's disease (PD) model mouse with a remarkable micron-level resolution. The imaging results revealed a significant increase in Cu2+ levels in the cerebral cortex as PD progresses, highlighting the close association between Cu2+ alternations in the region and the disease. We also demonstrated that the probe can be used to monitor changes in Cu2+ distribution in the PD model mouse brain during L-dopa intervention. Mechanism studies suggest that the copper dyshomeostasis in the PD mouse brain was dominated by the expression levels of divalent metal transporter 1. The application of our probe in imaging Cu2+ dynamics in the mouse brain offers valuable insights into the copper-related molecular mechanisms underlying neurodegenerative diseases.
chemistry, multidisciplinary
What problem does this paper attempt to address?
The paper aims to address the issue of high spatiotemporal resolution imaging of copper ions (Cu2+) in the mouse brain to gain a deeper understanding of the relationship between copper metabolism imbalance and neurodegenerative diseases. Specifically, the research team developed a small molecule ratiometric photoacoustic probe (PACu3) that enables high spatiotemporal resolution imaging of dynamic changes in Cu2+ within the mouse brain. The main contributions include: 1. **Probe Design and Performance**: By combining a copper-specific chelator with a near-infrared absorbing group capable of crossing the blood-brain barrier, the PACu3 probe was designed. This probe can selectively respond to Cu2+ and produce significant spectral changes upon chelation, allowing for ratiometric photoacoustic imaging. 2. **Biocompatibility and Permeability Validation**: The biocompatibility of the probe was validated through in vitro experiments, and its ability to cross the blood-brain barrier was assessed using parallel artificial membrane permeability assays. The results showed that PACu3 has good biocompatibility and high blood-brain barrier permeability. 3. **Application Example**: The developed probe was successfully used to achieve high-resolution imaging of Cu2+ concentration in the brains of Parkinson's disease (PD) model mice. The study found that as PD progresses, the Cu2+ levels in the mouse cerebral cortex significantly increase, revealing a close link between Cu2+ concentration changes and disease progression. 4. **Monitoring Therapeutic Intervention Effects**: Additionally, the probe was demonstrated to be useful for monitoring changes in Cu2+ distribution in the brains of PD model mice during L-dopa intervention. 5. **Mechanism Exploration**: Further mechanistic studies indicated that in the brains of PD mice, copper imbalance is primarily driven by the expression levels of divalent metal transporter 1 (DMT1). In summary, this work provides valuable insights into the molecular mechanisms underlying copper metabolism imbalance and neurodegenerative diseases, laying the foundation for the development of diagnostic and therapeutic strategies for related diseases in the future.